Le Lézard
Classified in: Health, Covid-19 virus
Subject: MISCELLANEOUS

TELUS Mental Health Index reveals workers lose 55 working days per year due to workplace conflict


TORONTO, Nov. 29, 2023 (GLOBE NEWSWIRE) -- TELUS Health today released its monthly TELUS Mental Health Index, revealing that workers who experience conflict at work lose an average of 55 work days per year. The Index also found that among workers in Canada, 26 per cent say better support for their wellbeing is more important than an increase in salary.

"The negative impacts of stress, whether stemming from external factors or internal dynamics within the workplace, have a ripple effect throughout an organization, impacting every level," said Juggy Sihota, Chief Growth Officer, TELUS Health. "The wellbeing of workers and the success of the business are inherently connected. By prioritizing investments in tools, processes and comprehensive benefits plans that foster a psychologically safe and supportive work environment, employers can cultivate a highly engaged and productive workforce that drives business outcomes."

Mental health and work-related stressors linked to productivity loss at work

Workers in Canada seek support for wellbeing through health benefits plans

"As mental health scores continue to be at a sub-optimal level, workers are increasingly aware that financial and mental wellbeing are deeply interconnected, and that overall wellbeing involves far more than just a salary," said Paula Allen, Global Leader, Research & Client Insights, TELUS Health. "In today's uncertain economic environment, it is very telling that workers are placing equal, if not greater, importance on wellbeing support compared to their salary. This highlights a significant opportunity for employers to meet employees' needs by providing resources and real-time support that go beyond financial considerations in order to maintain morale and ultimately retain top talent."

For the third consecutive month, the mental health score of workers in Canada has decreased, with the October 2023 score standing at 63.7, compared to the September score of 64.4.

The October TELUS Mental Health Index also includes important findings related to diagnosed and undiagnosed health conditions, work-life balance and expectations of COVID-19 policies in the workplace. Read the full Canadian TELUS Mental Health Index report findings here.

About the TELUS Mental Health Index
The survey by TELUS Health was conducted through an online survey in English and French from October 4 and October 10, 2023 with 3,000 respondents. All respondents reside in Canada and were employed within the last six months. The data has been statistically weighted to ensure the regional and gender composition of the sample reflects this population.

The TELUS Mental Health Index is based on a response scoring system that then turns individual responses into point values. Higher point values are associated with better mental health and less mental health risk. Scores between 0 to 49 correspond with distress levels, scores between 50 to 79 correspond with strain levels and scores between 80 to 100 correspond with optimal levels of mental health.

About TELUS Health
TELUS Health is a global healthcare leader providing comprehensive primary and preventive care services and solutions to improve physical, mental and financial wellbeing for employees and families worldwide. With our advanced technology and dedicated team members, including more than 100,000 compassionate health professionals, we are covering more than 69 million lives in 160 countries. We are on a mission to become the most trusted wellbeing company in the world by building the healthiest communities and workplaces on the planet through simplifying access to care and improving the flow of information between care providers, insurers, employers and individuals. For more information please visit: www.telushealth.com.

Media contact:

Marielle Hossack
TELUS Media Relations
[email protected] 



These press releases may also interest you

at 18:59
FINN Partners, a global independent marketing and communications agency, and Humble Ventures, a venture capital and private equity firm focused on diverse founders, entrepreneurs, start-ups and organizations, are joining forces for the second year in...

at 18:15
The "Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), and End User (Hospital, Imaging Center, Pharmaceutical) -...

at 18:00
Pacific Cataract and Laser Institute, Inc., P.C. ("Pacific Cataract and Laser") is providing notice of a recent data privacy event that may have affected the personal and protected health information related to certain individuals. At this time,...

at 18:00
The "Pharmaceutical Quality Management Systems Market by Solution Type (Deviation, CAPA, Audit, Risk & Compliance, Inspection, Document, Change, Training Management), Deployment Mode (Cloud, On-premise), and End User (Pharmaceutical, CDMO/CRO) -...

at 17:25
Spyre Therapeutics, Inc. (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment of Inflammatory Bowel...

at 17:21
Mezzion Pharmaceuticals is a rare disease company conducting the confirmatory pivotal phase 3 clinical trial in Fontan subjects: The Fontan Udenafil Exercise Longitudinal Assessment Trial- 2, or FUEL-2 trial. The company is pleased to announce Dr....



News published on and distributed by: